{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T21:00:55Z","timestamp":1774645255919,"version":"3.50.1"},"reference-count":36,"publisher":"The Endocrine Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,1,1]]},"DOI":"10.1210\/jc.2006-1197","type":"journal-article","created":{"date-parts":[[2007,1,6]],"date-time":"2007-01-06T03:08:24Z","timestamp":1168052904000},"page":"338-344","source":"Crossref","is-referenced-by-count":49,"title":["Accumulation of Nonphosphorylated \u03b2-Catenin and c-<i>myc<\/i>in Primary and Uremic Secondary Hyperparathyroid Tumors"],"prefix":"10.1210","volume":"92","author":[{"given":"Peyman","family":"Bjo\u0308rklund","sequence":"first","affiliation":[{"name":"Department of Surgical Sciences, Endocrine Unit, Uppsala University Hospital, SE-751 85 Uppsala, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Go\u0308ran","family":"A\u030akerstro\u0308m","sequence":"additional","affiliation":[{"name":"Department of Surgical Sciences, Endocrine Unit, Uppsala University Hospital, SE-751 85 Uppsala, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunnar","family":"Westin","sequence":"additional","affiliation":[{"name":"Department of Surgical Sciences, Endocrine Unit, Uppsala University Hospital, SE-751 85 Uppsala, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041114152333500_R1","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1056\/NEJM200012213432508","article-title":"Hyperparathyroid and hypoparathyroid disorders.","volume":"343","author":"Marx","year":"2000","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"key\n\t\t\t\t2019041114152333500_R2","first-page":"N30","article-title":"Molecular pathogenesis of primary hyperparathyroidism","volume":"17","author":"Arnold","year":"2002","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041114152333500_R3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00001622-200401000-00002","article-title":"Primary hyperparathyroidism.","volume":"16","author":"A\u030akerstro\u0308m","year":"2004","journal-title":"Curr Opin Oncol"},{"key":"key\n\t\t\t\t2019041114152333500_R4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1196\/annals.1327.005","article-title":"Parathyroid glands in calcium regulation and human disease.","volume":"1040","author":"A\u030akerstro\u0308m","year":"2005","journal-title":"Ann NY Acad Sci"},{"key":"key\n\t\t\t\t2019041114152333500_R5","first-page":"1736","article-title":"Cyclin D1\/PRAD1 expression in parathyroid adenomas: an immunohistochemical study.","volume":"81","author":"Hsi","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114152333500_R6","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1046\/j.1523-1755.1999.00396.x","article-title":"Expression of PRAD1\/cyclin D1, retinoblastoma gene products, and Ki67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenoma.","volume":"55","author":"Tominaga","year":"1999","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t2019041114152333500_R7","first-page":"412","article-title":"Expression of cyclin D1 in parathyroid carcinomas, adenomas, and hyperplasias: a paraffin immunohistochemical study.","volume":"12","author":"Vasef","year":"1999","journal-title":"Mod Pathol"},{"key":"key\n\t\t\t\t2019041114152333500_R8","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1172\/JCI10523","article-title":"Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice.","volume":"107","author":"Imanishi","year":"2001","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041114152333500_R9","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/350512a0","article-title":"A novel cyclin encoded by a bcl1-linked candidate oncogene.","volume":"350","author":"Motokura","year":"1991","journal-title":"Nature"},{"key":"key\n\t\t\t\t2019041114152333500_R10","first-page":"1108","article-title":"Genetic basis of endocrine disease 5. Molecular genetics of parathyroid gland neoplasia.","volume":"77","author":"Arnold","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114152333500_R11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0959-437X(99)80003-3","article-title":"The oncogenic activation of \u03b2-catenin.","volume":"9","author":"Polakis","year":"1999","journal-title":"Curr Opin Genet Dev"},{"key":"key\n\t\t\t\t2019041114152333500_R12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00432-003-0431-0","article-title":"The Wnt signaling pathway and its role in tumor development.","volume":"129","author":"Lustig","year":"2003","journal-title":"J Cancer Res Clin Oncol"},{"key":"key\n\t\t\t\t2019041114152333500_R13","first-page":"1","article-title":"Caught up in a Wnt storm: Wnt signaling in cancer.","volume":"1653","author":"Giles","year":"2003","journal-title":"Biochim Biophys Acta"},{"key":"key\n\t\t\t\t2019041114152333500_R14","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/nrg1427","article-title":"WNT and \u03b2-catenin signalling: diseases and therapies.","volume":"5","author":"Moon","year":"2004","journal-title":"Nat Rev Genet"},{"key":"key\n\t\t\t\t2019041114152333500_R15","first-page":"2967","article-title":"25-hydroxyvitamin D3-1\u03b1-hydroxylase expression in normal and pathological parathyroid glands.","volume":"87","author":"Segersten","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114152333500_R16","doi-asserted-by":"crossref","first-page":"17901","DOI":"10.1074\/jbc.M111635200","article-title":"Wnt signaling controls the phosphorylation status of \u03b2-catenin.","volume":"277","author":"Noort","year":"2002","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t2019041114152333500_R17","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1073\/pnas.97.7.3352","article-title":"APC mutations in sporadic colorectal tumors: a mutational \u201chotspot\u201d and interdependence of the \u201ctwo hits\u201d.","volume":"97","author":"Rowan","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t2019041114152333500_R18","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1126\/science.281.5382.1509","article-title":"Identification of c-MYC as a target of the APC pathway.","volume":"281","author":"He","year":"1998","journal-title":"Science"},{"key":"key\n\t\t\t\t2019041114152333500_R19","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1210\/endo-125-2-935","article-title":"Influence of calcium and 1,25-dihydroxycholecalciferol on proliferation and proto-oncogene expression in primary cultures of bovine parathyroid cells.","volume":"125","author":"Kremer","year":"1989","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t2019041114152333500_R20","first-page":"2681","article-title":"Analysis of proliferative activity of the parathyroid glands using proliferating cell nuclear antigen in patients with hyperparathyroidism.","volume":"82","author":"Yamaguchi","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114152333500_R21","doi-asserted-by":"crossref","first-page":"10330","DOI":"10.1073\/pnas.94.19.10330","article-title":"\u03b2-Catenin mutations in cell lines established from human colorectal cancers.","volume":"94","author":"Ilyas","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t2019041114152333500_R22","doi-asserted-by":"crossref","first-page":"8622","DOI":"10.1158\/0008-5472.CAN-05-2145","article-title":"The threshold level of adenomatous polyposis coli protein for mouse intestinal tumorigenesis.","volume":"65","author":"Li","year":"2005","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t2019041114152333500_R23","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/ng1045","article-title":"Apc modulates embryonic stem-cell differentiation by controlling the dosage of \u03b2-catenin signaling.","volume":"32","author":"Kielman","year":"2002","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t2019041114152333500_R24","first-page":"6656","article-title":"Accumulation of \u03b2-catenin protein and mutations in exon 3 of \u03b2-catenin gene in gastrointestinal carcinoid tumor.","volume":"61","author":"Fujimori","year":"2001","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t2019041114152333500_R25","doi-asserted-by":"crossref","first-page":"24735","DOI":"10.1074\/jbc.272.40.24735","article-title":"Serine phosphorylation-regulated ubiquitination and degradation of \u03b2-catenin.","volume":"272","author":"Orford","year":"1997","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t2019041114152333500_R26","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1126\/science.275.5307.1790","article-title":"Stabilization of \u03b2-catenin by genetic defects in melanoma cell lines.","volume":"275","author":"Rubinfeld","year":"1997","journal-title":"Science"},{"key":"key\n\t\t\t\t2019041114152333500_R27","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1385\/EP:11:3:243","article-title":"Nuclear accumulation of \u03b2-Catenin in human endocrine tumors: association with Ki-67 (MIB-1) proliferative activity.","volume":"11","author":"Semba","year":"2000","journal-title":"Endocr Pathol"},{"key":"key\n\t\t\t\t2019041114152333500_R28","first-page":"463","article-title":"Immunohistochemistry of cyclin D1 and \u03b2-catenin, and mutational analysis of exon 3 of \u03b2-catenin gene in parathyroid tumors.","volume":"20","author":"Ikeda","year":"2002","journal-title":"Int J Oncol"},{"key":"key\n\t\t\t\t2019041114152333500_R29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/gcc.2870130103","article-title":"Frequent loss of chromosome arm 1p DNA in parathyroid tumors.","volume":"13","author":"Cryns","year":"1995","journal-title":"Genes Chromosomes Cancer"},{"key":"key\n\t\t\t\t2019041114152333500_R30","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00000478-200201000-00014","article-title":"Familial adenomatous polyposis associated with multiple endocrine neoplasia type 1-related tumors and thyroid carcinoma.","volume":"26","author":"Sakai","year":"2002","journal-title":"Amer J Surg Pathol"},{"key":"key\n\t\t\t\t2019041114152333500_R31","doi-asserted-by":"crossref","first-page":"51606","DOI":"10.1074\/jbc.M310722200","article-title":"Phosphorylation by glycogen synthase kinase-3 controls c-myc proteolysis and subnuclear localization.","volume":"278","author":"Gregory","year":"2003","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t2019041114152333500_R32","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1242\/dev.01670","article-title":"LIF\/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism.","volume":"132","author":"Cartwright","year":"2005","journal-title":"Development"},{"key":"key\n\t\t\t\t2019041114152333500_R33","first-page":"1355","article-title":"Proof-of-principle: oncogenic \u03b2-catenin is a valid molecular target for the development of pharmacological inhibitors.","volume":"1","author":"Kim","year":"2002","journal-title":"Mol Cancer Ther"},{"key":"key\n\t\t\t\t2019041114152333500_R34","first-page":"1291","article-title":"Small interfering RNAs directed against \u03b2-catenin inhibit the in vitro and in vivo growth of colon cancer cells.","volume":"9","author":"Verma","year":"2003","journal-title":"Clin Cancer Res"},{"key":"key\n\t\t\t\t2019041114152333500_R35","doi-asserted-by":"crossref","first-page":"12682","DOI":"10.1073\/pnas.0404875101","article-title":"A small molecule inhibitor of \u03b2-catenin\/CREB-binding protein transcription.","volume":"101","author":"Emami","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t2019041114152333500_R36","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1535-6108(03)00334-9","article-title":"Small-molecule antagonists of the oncogenic Tcf\/\u03b2-catenin protein complex.","volume":"5","author":"Lepourcelet","year":"2004","journal-title":"Cancer Cell"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/92\/1\/338\/11059705\/jcem0338.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T16:46:13Z","timestamp":1587314773000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/92\/1\/338\/2598835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2006-1197","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,1]]}}}